These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19011663)

  • 1. Acute thyrotoxicosis after SCT.
    De Waele S; Van den Bruel A; Selleslag D; Van Den Berghe I; Decallonne B
    Bone Marrow Transplant; 2009 Apr; 43(8):663-4. PubMed ID: 19011663
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute complications of stem cell transplant.
    Rimkus C
    Semin Oncol Nurs; 2009 May; 25(2):129-38. PubMed ID: 19411016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal toxicity after bone marrow transplantation.
    Deconinck E; Cahn JY
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):661-2. PubMed ID: 14967417
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical outcome of Hurler syndrome after stem cell transplantation.
    Aldenhoven M; Boelens JJ; de Koning TJ
    Biol Blood Marrow Transplant; 2008 May; 14(5):485-98. PubMed ID: 18410891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyrotoxicosis after cord blood transplantation for acute myelogenous leukemia].
    Motohashi K; Sakai R; Hagihara M; Enaka M; Kanamori H; Maruta A; Ishigatsubo Y
    Rinsho Ketsueki; 2008 Dec; 49(12):1631-3. PubMed ID: 19110527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral, social, and educational outcomes after pediatric stem cell transplantation and related factors.
    Barrera M; Atenafu E; Pinto J
    Cancer; 2009 Feb; 115(4):880-9. PubMed ID: 19130461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review of the outcome after second or subsequent allogeneic transplantation.
    Kedmi M; Resnick IB; Dray L; Aker M; Samuel S; Gesundheit B; Slavin S; Or R; Shapira MY
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):483-9. PubMed ID: 19285636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
    Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway reactivity in children before and after stem cell transplantation.
    Bentur L; Lapidot M; Livnat G; Hakim F; Lidroneta-Katz C; Porat I; Vilozni D; Elhasid R
    Pediatr Pulmonol; 2009 Sep; 44(9):845-50. PubMed ID: 19670401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation].
    Aisa Y; Mori T; Shimizu T; Tsukada Y; Kato J; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2009 Jan; 50(1):9-15. PubMed ID: 19225223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.
    Willemze AJ; Bakker AC; von dem Borne PA; Bajema IM; Vossen JM
    Transplantation; 2009 Apr; 87(7):1096-101. PubMed ID: 19352133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of thyrotoxicosis.
    Allen EM; Braverman LE
    Compr Ther; 1987 Dec; 13(12):20-30. PubMed ID: 3326713
    [No Abstract]   [Full Text] [Related]  

  • 20. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
    Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.